Terms ending in 2032
Every in-force patent on 3-D Matrix, Ltd.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,905,708 | Microrna-Based Methods and Assays for Osteocarcinoma In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 11,260,072 | MicroRNA-based methods and assays for osteocarcinoma In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 9,322,016 | MicroRNA-Based Methods and Assays for Osteosarcoma In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.